바이오테크 보도자료
-
- Medidata Drives Diversity in Clinical Trials, Passing 30,000 Studies and 9 Million Participants
- Known for its ground-breaking technological innovations in clinical trials, Medidata, a Dassault Systèmes company, has exceeded 30,000 clinical trials and 9 million study participants. These milestones, achieved together with more than 2,100 globa...
- 2023년 03월 05일
-
- AIT Worldwide Logistics Expands Global Network, Pharmaceutical Logistics Expertise to South Korea
- Global freight forwarder AIT Worldwide Logistics is proud to announce its debut facility in the world‘s 10th largest economy with the opening of the company’s Seoul location, the first of several planned AIT offices in South Korea. According to AI...
- 2023년 03월 03일
-
- Carbios Doubles Its Number of Granted Patents in Two Years for Its Proprietary Enzymatic Technologies
- Regulatory News: Carbios (Euronext Growth Paris: ALCRB) (Paris:ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastics and textiles, has doubled its number of issued patents sinc...
- 2023년 03월 02일
-
- Aleph Farms Increases Production Capabilities with VBL Therapeutics Facility Acquisition and ESCO Aster Partnership
- Aleph Farms, the first company to grow cultivated steaks directly from non-modified cow cells, today announced that it has acquired a manufacturing facility in Modi’in, Israel, and certain related assets from biotechnology company VBL Therapeutics...
- 2023년 03월 02일
-
- GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
- GE HealthCare has today announced, at the European Congress of Radiology (ECR) in Vienna, Austria, the completion of Phase I subject recruitment in its early clinical development program for a first-of-its-kind manganese-based macrocyclic magnetic...
- 2023년 03월 02일
-
- Biocytogen’s Subsidiary Eucure Biopharma and Chipscreen Biosciences’ Holding Subsidiary Chipscreen NewWay Biosciences Enter into Greater China License Agreement for Bispecific Antibody YH008
- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced that its wholly owned subsidiary, Eucure (Beijing) Biopharma Co., Ltd. (“Eucure Biopharma”), has reached an exclusive licensing agreement with Chipscreen Ne...
- 2023년 02월 28일
-
- LevitasBio Launches LeviSelect Suite of Cell Depletion & Enrichment Kits
- LevitasBio, Inc. , a premier end-to-end sample processing and cellular analysis provider to the life sciences market, unveils a suite of LeviSelect™ cell depletion and enrichment kits for immunology research. LeviSelect Kits are a targeted expansi...
- 2023년 02월 23일
-
- Sinovac Amends Shareholder Rights Plan
- Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that its board of directors has amended its shareholder rights plan. The amendment extends the expiration d...
- 2023년 02월 23일
-
- Ferrer Acquires Worldwide Rights to ASN90, an O-GlcNAcase Inhibitor From Asceneuron, Exclusively to Treat Progressive Supranuclear Palsy (PSP)
- Spanish pharmaceutical company Ferrer and Swiss clinical stage biotechnology company Asceneuron announce the signing of a licensing agreement in which Ferrer obtains the exclusive worldwide rights to develop and commercialize ASN90 in progressive ...
- 2023년 02월 23일
-
- Medidata Bolsters Senior Leadership Team to Further Accelerate the Digital Transformation of Life Sciences with Unmatched End-to-End Solutions
- Medidata, a Dassault Systèmes company, today announced a new leadership structure designed to fuel its mission of creating end-to-end solutions that power smarter treatments and healthier people. The strategic evolution is an opportunity to furthe...
- 2023년 02월 22일
전시회
